These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32227680)

  • 1. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
    Feißt M; Krisam J; Kieser M
    Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
    Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
    Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel power prior approach for borrowing historical control data in clinical trials.
    Shi Y; Li W; Liu GF
    Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
    Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
    Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating historical information in biosimilar trials: Challenges and a hybrid Bayesian-frequentist approach.
    Mielke J; Schmidli H; Jones B
    Biom J; 2018 May; 60(3):564-582. PubMed ID: 29532950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elastic priors to dynamically borrow information from historical data in clinical trials.
    Jiang L; Nie L; Yuan Y
    Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical Bayesian adaptive design incorporating data from historical controls.
    Psioda MA; Soukup M; Ibrahim JG
    Stat Med; 2018 Nov; 37(27):4054-4070. PubMed ID: 30033617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of historical control data for assessing treatment effects in clinical trials.
    Viele K; Berry S; Neuenschwander B; Amzal B; Chen F; Enas N; Hobbs B; Ibrahim JG; Kinnersley N; Lindborg S; Micallef S; Roychoudhury S; Thompson L
    Pharm Stat; 2014; 13(1):41-54. PubMed ID: 23913901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.
    Lee SY
    BMC Med Res Methodol; 2024 May; 24(1):110. PubMed ID: 38714936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian hierarchical model for dose-finding trial incorporating historical data.
    Han L; Deng Q; He Z; Fleischer F; Yu F
    J Biopharm Stat; 2024 Aug; 34(5):646-660. PubMed ID: 37676029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian design of a survival trial with a cured fraction using historical data.
    Psioda MA; Ibrahim JG
    Stat Med; 2018 Nov; 37(26):3814-3831. PubMed ID: 29938817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.
    Isogawa N; Takeda K; Maruo K; Daimon T
    Ther Innov Regul Sci; 2020 May; 54(3):559-570. PubMed ID: 33301135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian borrowing from historical control data in a vaccine efficacy trial.
    Peng L; Jin J; Chambonneau L; Zhao X; Zhang J
    Pharm Stat; 2023; 22(5):815-835. PubMed ID: 37226586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust incorporation of historical information with known type I error rate inflation.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.